Table 1.
Characteristics of study patients
| Latanoprost (n = 87) | Bimatoprost (n = 35) | Travoprost (n = 26) | Timolol (n = 43) | P value | |
|---|---|---|---|---|---|
| Age (years), mean ± SD | 64.8 (12.8) | 68.5 (14.05) | 67.5 (16.8) | 67.5 (14.4) | NS |
| Gender, n (%) | 0.002 | ||||
| Males | 30 (34.5) | 24 (68.6) | 7 (26.9) | 21 (48.8) | |
| Females | 57 (65.5) | 11 (31.4) | 19 (73.1) | 22 (51.2) | |
| Last IOP value (mmHg), mean ± SD | 16.6 (2.7) | 17.0 (2.9) | 17 (2.5) | 17.4 (3.4) | NS |
| Glaucoma (years)*, median ± SD | 2.5 (4.1) | 2.8 (2.9) | 1.6 (1.5) | 1.4 (3.5) | NS |
| Previous glaucoma treatment, n (%) | 40 (46) | 26 (74.3) | 8 (30.8) | 11 (25.6) | 0.00011 |
| Associated comorbidities, n (%) | NS | ||||
| None | 47 (54) | 18 (51.4) | 6 (23.1) | 20 (46.5) | |
| Cardiovascular (includes diabetes) | 31 (35.6) | 12 (34.3) | 16 (61.5) | 21 (48.8) | |
| Ophthalmologic | 8 (9.2) | 5 (14.3) | 3 (11.5) | 1 (2.3) | |
| Neurologic | 1 (1.1) | 0 (0) | 1 (3.8) | 1 (2.3) |
Notes:
*
Time since glaucoma diagnosis (years).
**
Including diabetes mellitus.
Abbreviation: NS, not statistically significant.